Concert Pharmaceuticals, Inc. Soared
Thu, Nov 04, 2021 at 05:30 PM
Concert Pharmaceuticals, Inc. (CNCE:NASDAQ) rocketted at $3.67, a gain of 27.4%. On Wed, Nov 03, 2021, CNCE:NASDAQ touched a New 2-Week High of $2.88. The stock got featured on our News Catalysts scanner on Tue, Nov 02, 2021 at 07:51 AM in the 'EARNINGS' category. From Wed, Oct 20, 2021, the stock recorded 60.00% Up Days and 54.55% Green Days
The share price of the company has been moving sideways in recent weeks.
About Concert Pharmaceuticals, Inc. (CNCE:NASDAQ)
Concert Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It aims to discover and develop small-molecule drugs for new treatments to cure cystic fibrosis, inflammation, narcolepsy, residual schizophrenia, and Alzheimer's agitation.
Top 10 Gainers:
- EVAX (EVAX:NASDAQ), 95.08%
- TDH Holdings, Inc. (PETZ:NASDAQ), 79.75%
- Cassava Sciences, Inc. (SAVA:NASDAQ), 48.96%
- RDBX (RDBX:NASDAQ), 45.06%
- NeoPhotonics Corporation (NPTN:NYSE), 38.8%
- ADTX (ADTX:NASDAQ), 36.41%
- Keros Therapeutics, Inc. (KROS:NASDAQ), 27.69%
- Concert Pharmaceuticals, Inc. (CNCE:NASDAQ), 27.43%
- ASXC (ASXC:NYSEMKT), 24.86%
- VLCN (VLCN:NASDAQ), 24.52%